HCTI
HCTI
Healthcare Triangle, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $3.49M ▼ | $3.21M ▲ | $-1.91M ▼ | -54.63% ▼ | $-89.92 ▼ | $-1.81M ▼ |
| Q2-2025 | $3.56M ▼ | $1.85M ▲ | $-1.37M ▲ | -38.45% ▲ | $-64.54 ▲ | $-1.35M ▼ |
| Q1-2025 | $3.7M ▲ | $1.73M ▲ | $-1.7M ▼ | -45.9% ▲ | $-80.2 ▼ | $-1.27M ▼ |
| Q4-2024 | $2.19M ▼ | $754K ▼ | $-1.35M ▼ | -61.55% ▼ | $-59.23 ▼ | $-636K ▲ |
| Q3-2024 | $2.41M | $1.89M | $-1.25M | -51.76% | $-54.89 | $-824K |
What's going well?
Gross profit improved thanks to lower product costs, and the company is not burdened by debt or taxes. Revenue is holding fairly steady.
What's concerning?
Operating expenses ballooned, leading to much bigger losses. The company is burning cash and not showing signs of cost control, with unusual accounting in sales and marketing.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.63M ▼ | $13.84M ▼ | $5.11M ▲ | $8.74M ▼ |
| Q2-2025 | $3.23M ▼ | $14.57M ▲ | $4.36M ▲ | $10.21M ▲ |
| Q1-2025 | $6.83M ▲ | $11.79M ▲ | $3.21M ▼ | $8.58M ▲ |
| Q4-2024 | $20K ▼ | $1.96M ▼ | $7.08M ▲ | $-5.11M ▼ |
| Q3-2024 | $28K | $4.77M | $6.58M | $-1.82M |
What's financially strong about this company?
They still have positive equity and enough current assets to cover near-term bills. Over half of their assets are liquid, mostly in receivables and cash.
What are the financial risks or weaknesses?
Cash is dropping fast, debt is rising sharply, and the company has a long history of losses. Most assets are intangible, and book value is falling.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-1.91M ▼ | $-1.96M ▲ | $-686K ▼ | $1.05M ▲ | $-1.6M ▲ | $-2.65M ▲ |
| Q2-2025 | $-1.37M ▲ | $-2.63M ▲ | $-603K ▼ | $-360K ▼ | $-3.6M ▼ | $-3.24M ▲ |
| Q1-2025 | $-1.7M ▼ | $-5.56M ▼ | $0 | $12.36M ▲ | $6.81M ▲ | $-5.56M ▼ |
| Q4-2024 | $-1.35M ▼ | $-811K ▼ | $0 | $803K ▲ | $-8K ▼ | $-811K ▼ |
| Q3-2024 | $-1.25M | $715K | $0 | $-716K | $-1K | $715K |
What's strong about this company's cash flow?
Cash burn is shrinking each quarter, showing some improvement in managing expenses. The company was able to raise outside funding to keep operations going.
What are the cash flow concerns?
The company is still losing real cash every quarter and now depends on raising new money to survive. Cash reserves are running dangerously low, and without more funding, the business could run out of money soon.
Revenue by Products
| Product | Q4-2022 | Q1-2023 | Q2-2023 | Q3-2023 |
|---|---|---|---|---|
 Managed Services And Support | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Platform Services | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Software Services | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $0 ▼ |
5-Year Trend Analysis
A comprehensive look at Healthcare Triangle, Inc.'s financial evolution and strategic trajectory over the past five years.
Healthcare Triangle brings specialized expertise in a complex and regulated sector, with platforms and certifications tailored to healthcare and life sciences. Its strategic focus on AI, data, and cloud-based SaaS aligns well with long-term industry trends, and recent cost actions have reduced cash burn and narrowed losses. Strong relationships with major cloud providers and a portfolio of proprietary solutions provide a foundation that could support a more recurring, higher-margin business mix if the transition is successful.
The financial profile is the central concern: revenues have collapsed, losses remain substantial, equity has turned negative, and cash is extremely limited, all of which point to heightened liquidity and solvency risk. The sharp reduction in R&D and investment spending, while helpful for short-term cash preservation, may undermine the depth and pace of innovation. Competitive pressures from larger and better-funded players, alongside execution risks in integrating acquisitions and scaling new SaaS offerings, add further uncertainty.
The outlook is highly uncertain and hinges on the company’s ability to stabilize and then rebuild revenue while repairing its balance sheet. In the near term, survival and liquidity management appear to dominate over growth, with continued reliance on external capital or restructuring measures likely. Over the longer term, if Healthcare Triangle can convert its AI and SaaS strategy into tangible customer wins and recurring revenue, it could emerge as a specialized niche player, but the path is narrow and the financial risks are elevated.
About Healthcare Triangle, Inc.
https://www.healthcaretriangle.comHealthcare Triangle, Inc., a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $3.49M ▼ | $3.21M ▲ | $-1.91M ▼ | -54.63% ▼ | $-89.92 ▼ | $-1.81M ▼ |
| Q2-2025 | $3.56M ▼ | $1.85M ▲ | $-1.37M ▲ | -38.45% ▲ | $-64.54 ▲ | $-1.35M ▼ |
| Q1-2025 | $3.7M ▲ | $1.73M ▲ | $-1.7M ▼ | -45.9% ▲ | $-80.2 ▼ | $-1.27M ▼ |
| Q4-2024 | $2.19M ▼ | $754K ▼ | $-1.35M ▼ | -61.55% ▼ | $-59.23 ▼ | $-636K ▲ |
| Q3-2024 | $2.41M | $1.89M | $-1.25M | -51.76% | $-54.89 | $-824K |
What's going well?
Gross profit improved thanks to lower product costs, and the company is not burdened by debt or taxes. Revenue is holding fairly steady.
What's concerning?
Operating expenses ballooned, leading to much bigger losses. The company is burning cash and not showing signs of cost control, with unusual accounting in sales and marketing.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.63M ▼ | $13.84M ▼ | $5.11M ▲ | $8.74M ▼ |
| Q2-2025 | $3.23M ▼ | $14.57M ▲ | $4.36M ▲ | $10.21M ▲ |
| Q1-2025 | $6.83M ▲ | $11.79M ▲ | $3.21M ▼ | $8.58M ▲ |
| Q4-2024 | $20K ▼ | $1.96M ▼ | $7.08M ▲ | $-5.11M ▼ |
| Q3-2024 | $28K | $4.77M | $6.58M | $-1.82M |
What's financially strong about this company?
They still have positive equity and enough current assets to cover near-term bills. Over half of their assets are liquid, mostly in receivables and cash.
What are the financial risks or weaknesses?
Cash is dropping fast, debt is rising sharply, and the company has a long history of losses. Most assets are intangible, and book value is falling.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-1.91M ▼ | $-1.96M ▲ | $-686K ▼ | $1.05M ▲ | $-1.6M ▲ | $-2.65M ▲ |
| Q2-2025 | $-1.37M ▲ | $-2.63M ▲ | $-603K ▼ | $-360K ▼ | $-3.6M ▼ | $-3.24M ▲ |
| Q1-2025 | $-1.7M ▼ | $-5.56M ▼ | $0 | $12.36M ▲ | $6.81M ▲ | $-5.56M ▼ |
| Q4-2024 | $-1.35M ▼ | $-811K ▼ | $0 | $803K ▲ | $-8K ▼ | $-811K ▼ |
| Q3-2024 | $-1.25M | $715K | $0 | $-716K | $-1K | $715K |
What's strong about this company's cash flow?
Cash burn is shrinking each quarter, showing some improvement in managing expenses. The company was able to raise outside funding to keep operations going.
What are the cash flow concerns?
The company is still losing real cash every quarter and now depends on raising new money to survive. Cash reserves are running dangerously low, and without more funding, the business could run out of money soon.
Revenue by Products
| Product | Q4-2022 | Q1-2023 | Q2-2023 | Q3-2023 |
|---|---|---|---|---|
| Managed Services And Support | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
| Platform Services | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
| Software Services | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $0 ▼ |
5-Year Trend Analysis
A comprehensive look at Healthcare Triangle, Inc.'s financial evolution and strategic trajectory over the past five years.
Healthcare Triangle brings specialized expertise in a complex and regulated sector, with platforms and certifications tailored to healthcare and life sciences. Its strategic focus on AI, data, and cloud-based SaaS aligns well with long-term industry trends, and recent cost actions have reduced cash burn and narrowed losses. Strong relationships with major cloud providers and a portfolio of proprietary solutions provide a foundation that could support a more recurring, higher-margin business mix if the transition is successful.
The financial profile is the central concern: revenues have collapsed, losses remain substantial, equity has turned negative, and cash is extremely limited, all of which point to heightened liquidity and solvency risk. The sharp reduction in R&D and investment spending, while helpful for short-term cash preservation, may undermine the depth and pace of innovation. Competitive pressures from larger and better-funded players, alongside execution risks in integrating acquisitions and scaling new SaaS offerings, add further uncertainty.
The outlook is highly uncertain and hinges on the company’s ability to stabilize and then rebuild revenue while repairing its balance sheet. In the near term, survival and liquidity management appear to dominate over growth, with continued reliance on external capital or restructuring measures likely. Over the longer term, if Healthcare Triangle can convert its AI and SaaS strategy into tangible customer wins and recurring revenue, it could emerge as a specialized niche player, but the path is narrow and the financial risks are elevated.
CEO
Lakshmanan Kannappan
Compensation Summary
(Year )
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2026-02-10 | Reverse | 1:60 |
| 2025-08-01 | Reverse | 1:249 |
ETFs Holding This Stock
Summary
Showing Top 2 of 2
Ratings Snapshot
Rating : C